Search
for
Sort by
Research 421–450 of 1000+
- Topical Treatment for Scarring and Non-Scarring Alopecia: An Overview of the Current Evidence
- RETRACTED: Modern techniques in addressing facial acne scars: A thorough analysis
- Updates in the understanding and treatments of skin & hair disorders in women of color
- Role of topical tofacitinib in autoimmune skin disorders: An expert opinion
- Clinical and sociodemographic features of alopecia areata in five Colombian cities: an analysis of the RENAAC registry
- Cosmetic Approach for Men
- Controversies in the treatment of androgenetic alopecia: The history of finasteride
- Medicinal and cosmetic products used in treatment of hair loss
- A Survey of Patient Attitudes Towards Topical Minoxidil in the Treatment of Hair Loss.
- A Review on the Ethnomedicinal Plants Used in Zimbabwe for the Treatment and Management of Skin Conditions: Perspectives on Pharmacological and Toxicological Evaluation
- Reporting on Adverse Clinical Events
- ANNOUNCEMENTS
- Psoriasis
- Acneiform Dermatoses
- Psychoactive drugs and skin
- Docetaxel-induced Psoriasis
- Engineering a 3D wounded skin equivalent to study early inflammatory and regenerative responses in vitro
- Sorafenib-induced eruption resembling pityriasis rubra pilaris
- Methotrexate/tacrolimus/voriconazole
- Modern aspects of external application and prospects of using the secretome of mesenchymal stem cells (review)
- Transient perforating folliculitis induced by sorafenib
- Topical absorption and systemic toxicity
- RESPOSTA TERAPÊUTICA DA ALOPÉCIA ANDROGENÉTICA APÓS DRUG DELIVERY DIGITAL COM APLICAÇÃO DE PRODEW 500®, NANOFACTOR® AFGF, NANOFACTOR® VEGF, COPPER PEPTÍDEO®, PROHAIRIN B4®, CAPILLISIL HC® E ARCT-ALG®
- Formulation And Evaluation of Controlled-Release Minoxidil Nanogels for Topical Application
- Sorafenib-Associated Facial Acneiform Eruption
- Clinical utility and validity of minoxidil response testing in androgenetic alopecia
- PROTECTION AGAINST CYTOSINE ARABINOSIDE-INDUCED ALOPECIA BY MINOXIDIL IN A RAT ANIMAL MODEL
- Non‐biologic immunosuppressive drugs for inflammatory and autoimmune skin diseases
- A method to improve the efficacy of topical eflornithine hydrochloride cream
- Editorial: Exploring innovative therapies for rare inflammatory skin diseases